Rexahn Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Due Diligence for Asset Managers
Analyze the public filings of asset managers
Dive into the EDGAR, IAPD, CAFR source data
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Rexahn Pharmaceuticals Inc
TickerIRD
CIK #0001228627
CUSIP67577R102
SectorLife Sciences - Pharmaceutical Preparations
Address15245 Shady Grove Road, Suite 455, Rockville, MD 20850
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Opus Genetics Inc 2024-11-07 25.8 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
Ocuphire Pharma Inc 2020-11-20 21.1 M Exemption: 506(b) · Duration: One year or less · Commission: $1,600,000 · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001228627] 10-K
[0001228627] 10-Q
[0001228627] 3
[0001228627] 4
[0001228627] 5
[0001228627] 8-K
[0001228627] D
[0001228627] SC 13D
[0001228627] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Caligan Partners LP Opus Genetics Inc [2026-05-15] 0.0
Adage Capital Management LP Opus Genetics Inc [2026-05-13] 0.0
Balyasny Asset Management LP Opus Genetics Inc [2026-02-17] 0.0
BIOS Fund III LP Opus Genetics Inc [2025-08-11] 0.0
Nantahala Capital Management LLC Opus Genetics Inc [2025-05-15] 0.0
Perceptive Advisors LLC Opus Genetics Inc [2025-03-31] 0.0
Foundation Fighting Blindness Retinal Degeneration Fund Opus Genetics Inc [2024-10-29] 81948.16
Richmond Brothers Inc Ocuphire Pharma Inc [2022-05-17] 5.84
Apexian Pharmaceuticals Inc Ocuphire Pharma Inc [2021-03-26] 7.136
Sooch Mina Ocuphire Pharma Inc [2021-03-17] 11.8
Altium Capital Management LP Ocuphire Pharma Inc [2020-11-16] 8.3
Richmond Brothers Inc Ocuphire Pharma Inc [2020-11-16] 1.0
Empery Asset Management LP Ocuphire Pharma Inc [2020-11-12] 7.58
Armistice Capital LLC Rexahn Pharmaceuticals Inc [2020-08-10] 1.0
Armistice Capital LLC Rexahn Pharmaceuticals Inc [2019-02-05] 4.99
Anson Funds Management LP Rexahn Pharmaceuticals Inc [2018-10-29] 5.1
CVI Investments Inc Rexahn Pharmaceuticals Inc [2018-10-26] 5.1
Sabby Management LLC Rexahn Pharmaceuticals Inc [2016-02-29] 4.89
Empery Asset Management LP Rexahn Pharmaceuticals Inc [2015-11-10] 8.44
Sabby Management LLC Rexahn Pharmaceuticals Inc [2012-12-04] 6.41
Form 3/4/5 Filer 2011 - 2026
Foundation Fighting Blindness Inc
Foundation Fighting Blindness Retinal Degeneration Fund
Rexahn Pharmaceuticals Inc
Magrath George
Jayagopal Ashwath
Zaremba Rabourn Amy
Yerxa Benjamin R
Gagnon Robert E
Schachle Joseph K
Bennett Jean
Benton Susan
Gallagher Cam
Graves Adrienne L
Manuso James S J
Rodgers Richard J
Ainsworth Sean
Hoffmann Bernhard
Jhaveri Nirav S
Pepose Jay
Patel Ronil A
Sooch Mina
Meyer Alan R
Sullivan Lara
Brandt Peter C
Price Ben Gil
Beever Charles
Cheong Kwang Soo
Nolan Lisa
Benaim Ely
Swirsky Douglas J
Suzdak Peter David
Ahn Chang Ho
Carthy Mark
Jeong Tae Heum
Hwang Si Moon
McIntosh David M
Soni Rakesh
Kivel Richard
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Magrath George
Common Stock
2026-03-16 Sell 24,438 $5.21 127,322
Schachle Joseph K
Common Stock
2026-03-16 Sell 3,719 $5.25 19,525
Jayagopal Ashwath
Common Stock
2026-03-16 Sell 3,719 $5.12 19,041
Zaremba Rabourn Amy
Common Stock
2026-03-16 Sell 2,816 $5.25 14,784
Jayagopal Ashwath
Common Stock
2026-02-12 Tax withheld 5,313 $3.39 18,011
Zaremba Rabourn Amy
Common Stock
2026-01-22 Grant 86,500 $0.00
Schachle Joseph K
Common Stock
2026-01-22 Grant 250,000 $0.00
Yerxa Benjamin R
Common Stock
2026-01-22 Grant 400,000 $0.00
Magrath George
Common Stock
2026-01-22 Grant 483,639 $0.00
Gagnon Robert E
Common Stock
2026-01-22 Grant 400,000 $0.00
Jayagopal Ashwath
Common Stock
2026-01-22 Grant 400,000 $0.00
Zaremba Rabourn Amy
Common Stock
2026-01-18 Tax withheld 3,390 $2.10 7,119
Zaremba Rabourn Amy
Common Stock
2026-01-10 Tax withheld 3,950 $1.93 7,624
Gallagher Cam
Common Stock
2026-01-06 Grant 67,000 $0.00
Graves Adrienne L
Common Stock
2026-01-01 Grant 23,643
Ainsworth Sean
Common Stock
2026-01-01 Grant 42,507
Manuso James S J
Common Stock
2026-01-01 Grant 31,188
Bennett Jean
Common Stock
2026-01-01 Grant 21,127
Gallagher Cam
Common Stock
2025-12-31 Grant 33,000 $0.00
Gallagher Cam
Common Stock
2025-12-29 Buy 81,000 $1.98 160,380
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 79 45,469,735
2025-12-31 59 27,858,568
2025-09-30 48 19,036,304
2025-06-30 45 17,637,556
2025-03-31 47 14,575,016
2024-12-31 44 3,693,276
2024-09-30 39 2,546,502
2024-06-30 37 2,700,102
2024-03-31 49 3,532,945
2023-12-31 50 3,796,396
2023-09-30 51 3,825,350
2023-06-30 53 3,958,843
Form 13F Holdings
Firm Period DFND Voting Shares
First City Capital Management Inc [2026-06-30] SOLE 0 11,836
Farther Finance Advisors LLC [2026-06-30] SOLE 0 3,490
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com